ACS:CENTAUR PSA2 IMMUNOASSAY

Prostate-specific Antigen (psa) For Management Of Prostate Cancers

CHIRON DIAGNOSTICS CORP.

The following data is part of a premarket notification filed by Chiron Diagnostics Corp. with the FDA for Acs:centaur Psa2 Immunoassay.

Pre-market Notification Details

Device IDK981839
510k NumberK981839
Device Name:ACS:CENTAUR PSA2 IMMUNOASSAY
ClassificationProstate-specific Antigen (psa) For Management Of Prostate Cancers
Applicant CHIRON DIAGNOSTICS CORP. 63 NORTH ST. Medfield,  MA  02052
ContactWilliam J Pignato
CorrespondentWilliam J Pignato
CHIRON DIAGNOSTICS CORP. 63 NORTH ST. Medfield,  MA  02052
Product CodeLTJ  
CFR Regulation Number866.6010 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1998-05-26
Decision Date1998-08-12
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.